RECQL5 and breast cancer: However, in the case of RECQL5, the outcome was different and encouraging, given that, within our 1993 samples, we found six LoF or likely LoF variants (Table 2) obtaining an OR of 2.07 (p = 0.127; 95% CI, 0.76–4.89), thus confirming its tendency as BC-susceptibility gene (Tavera-Tapia et al., 2019).